The purpose of this study was to investigate the potential role of the cyclin D1 gene G870A polymorphism in the likelihood of the development of lung cancer and the overall survival of lung cancer patients in the North Indian population.
Methods
The study consisted of 353 lung cancer cases and 351 age- and gender-matched healthy controls. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLPP) was done for the CCND1 gene. The association analysis was done using the multiple linear regression, and the survival analysis was done using the Kaplan-Meier and the Cox regression models.
Results
The GA genotype was associated with an increased risk for overall lung cancer (odds ratio [OR] = 1.63; p = 0.01). Combined variant genotype showed a significant association for overall lung cancer (OR 1.50; p = 0.03). In addition, smokers with the carrier genotype of CCND1 were found to have a significantly higher risk for lung cancer (OR 1.57; p = 0.04). No significant correlation was observed between the overall survival of lung cancer patients and CCND1 polymorphism. However, on stratifying the subjects on the basis of histology, it was evident that small-cell lung cancer (SCLC) patients carrying the mutant (AA) genotype showed nearly a fivefold increased mortality rate compared to the wild (GG) genotype (p = 0.03).
Conclusions
Our results suggest that polymorphic CCND1 may increase the risk of lung cancer in smokers from North India, and it may be associated with the overall survival of SCLC patients.
BrayFGLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No.11. Lyon, France: International Agency for Research on Cancer2013http://globocan.iarc.fr, accessed on day/month/year. Accessed November 23, 2017.
2.
WoganGNHechtSSFeltonJSConneyAHLoebLAEnvironmental and chemical carcinogenesis.Semin Cancer Biol2004146473–486
3.
AmosCIXuWSpitzMRIs there a genetic basis for lung cancer susceptibility?Recent Results Cancer Res19991513–12
4.
ShahPPSinghAPSinghMet al.Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.Mutat Res20086391-21–10
5.
ParkMTLeeSJCell cycle and cancer.J Biochem Mol Biol200336160–65
6.
CaputiMGroegerAMEspositoVet al.Prognostic role of cyclin D1 in lung cancer.Relationship to proliferating cell nuclear antigen. Am J Respir Cell Mol Biol1999204746–750
7.
KnudsenKEDiehlJAHaimanCAKnudsenESCyclin D1: polymorphism, aberrant splicing and cancer risk.Oncogene200625111620–1628
8.
GautschiORatschillerDGuggerMBetticherDCHeighwayJCyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.Lung Cancer20075511–14
9.
ZhouCAnHHuMet al.The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.Tumour Biol20133463831–3837
10.
GuptaVKFeberAXiLet al.Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.Clin Cancer Res200814237804–7812
11.
ShuXOMooreDBCaiQet al.Association of cyclin D1 genotype with breast cancer risk and survival.Cancer Epidemiol Biomarkers Prev200514191–97
12.
GautschiOHugliBZieglerAet al.Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.Lung Cancer2006513303–311
13.
PanovSZMolecular biology of the lung cancer.Radiol Oncol2005393197–210
14.
TashiroETsuchiyaAImotoMFunctions of cyclin D1 as an oncogene and regulation of cyclin D1 expression.Cancer Sci2007985629–635
15.
BuchSCDiergaardeBNukuiTet al.Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer.Mol Carcinog201251S1 Suppl 1E11–E20
16.
HoYSChenCHWangYJet al.Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation.Toxicol Appl Pharmacol20052052133–148
17.
SodhiKKBahlCSinghNBeheraDSharmaSFunctional genetic variants in pre-miR-146a and 196a2 genes are associated with risk of lung cancer in North Indians.Future Oncol201511152159–2173
18.
SatinderKChanderSRPushpinderKInduGVeenaJCyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population.Mol Cell Biochem20083151-2151–157
19.
KumariABahlCSinghNBeheraDSharmaSAssociation of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.Mol Biol Rep201643121383–1394
20.
SobtiRCKaurPKaurSet al.Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.Cancer Genet Cytogenet20061702108–114
21.
HongYEuKWSeow-ChoenFFook-ChongSCheahPYGG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore.Eur J Cancer20054171037–1044
22.
FengBJHuangWShugartYYet al.Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4.Nat Genet2002314395–399
23.
CatarinoRJBredaECoelhoVet al.Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma.Head Neck2006287603–608
24.
ChienCRSuSYCohenLLinHWLeeRTShihYCUse of Chinese medicine among survivors of nasopharyngeal carcinoma in Taiwan: a population-based study.Integr Cancer Ther2012113221–231
25.
WangLHabuchiTTakahashiTet al.Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.Carcinogenesis200223257e64
26.
JiangJWangJSuzukiSet al.Elevated risk of colorectal cancer associated with AA genotype of the cyclin D1 A870G polymorphism in an Indian population.J Cancer Res Clin Oncol2006132193e9
27.
QiulingSYuxinZSuhuaZChengXShuguangLFengshengHCyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population.Carcinogenesis20032491499–1503
28.
McKayJAGithangaJIndaloAet al.Distinct differences in a cyclin D1 single nucleotide polymorphism between ethnic groups.GeneScreen200113139–142
29.
KripplPLangsenlehnerURennerWet al.The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer.Breast Cancer Res Treat2003823165–168
30.
McKayJADouglasJJRossVGCurranSMurrayGICassidyJAberdeen Colorectal Initiative.Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Int J Cancer200088177–81
31.
LinYCYehCJWangLHLeeCWChenCHThe effect of CCND1 +870A>G and VEGF +936C>T polymorphisms on oral cancer development and disease-free survival in a Taiwan population.Oral Oncol2012486535–540
32.
HsiaTCLiuCJLinCHet al.Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients.Anticancer Res201131103601–3605
33.
AkkizHBayramSBekarAAkgöllüEÖzdilBCyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study.Cancer Epidemiol2010343298–302
34.
GuptaVKFeberAXiLet al.Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.Clin Cancer Res200814237804–7812
35.
BetticherDCHeighwayJHasletonPSet al.Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.Br J Cancer1996733294–300
